ArticleNeurology and therapy2025

Administration and Monitoring Burden of High-Efficacy Disease-Modifying Therapies for Multiple Sclerosis: A Delphi Consensus of Clinical Experts from Saudi Arabia.

Seraj Makkawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.